GlassScriptPhysician profile
Susan Kovacich
NPI 1700855327
$5,911.03
in general payments reported to CMS, 2019-2025
16 companies · $729 in 2025
The $729 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,434 · 2020: $161 · 2021: $202 · 2022: $386 · 2023: $332 · 2024: $1,667 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726 · Travel and Lodging: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,725.93 |
| Travel and Lodging | $1,001.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,313.63 | 2019-2025 | Rocklatan, Precision 7 |
| Coopervision INC. | $962.10 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $243.19 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $237.37 | 2025 | Miebo, Vyzulta, Xiidra |
| Johnson & Johnson Vision Care, INC. | $165.85 | 2023-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $143.71 | 2025 | |
| Mallinckrodt Hospital Products INC. | $124.29 | 2024 | Acthar |
| Apellis Pharmaceuticals, INC. | $113.81 | 2025 | |
| Abbvie INC. | $94.85 | 2022 | |
| Astellas Pharma Global Development | $91.93 | 2025 | Izervay |
| Shire North American Group INC | $83.24 | 2019 | |
| Glaukos Corporation | $82.85 | 2019 | |
| Sun Pharmaceutical Industries INC. | $82.79 | 2022 | |
| Quidel Corporation | $79.66 | 2023 | |
| Allergan, INC. | $77.95 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $13.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Kovacich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.